The ability to plan several steps ahead and promptly adapt to a rapidly changing environment is essential to being an elite ...

A neuroimaging study of torture survivors found that these individuals exhibit decreased connectivity in brain networks ...

We are thrilled to welcome Matt to Verastem Oncology at an important time as we prepare for a mid-2025 product launch and the transition into a commercial-stage company, while we continue to advance ...

INCHEON, South Korea I January 14, 2025 I Celltrion, Inc. (068270.KS), a leading global biopharmaceutical company, today announced its innovative drug ...

A new study showed that SOCS1 regulation of GM-CSF signaling is dose-dependent. The study, which involved generating a novel ...

The FIP has released the disciplinary measures related to the 15th day of Serie A basketball. There are three companies fined ...

H.C. Wainwright analyst Emily Bodnar maintained a Hold rating on Ventyx Biosciences (VTYX – Research Report) today. The company’s shares opened ...

Both HFDs and high-sugar diets (HSDs) increase impulsive behavior. Prior research suggests that HFDs may increase ...

First subjects dosed in a Phase 2 trial of VTX3232 in participants with obesity and cardiometabolic risk factors, with topline data expected in ...

Indianapolis: Eli Lilly and Company and Scorpion Therapeutics, Inc., a private biotechnology company developing small ...

The participants were categorized as early childhood-onset asthma (asthma at baseline and follow-up), later childhood-onset ...

Munich, Germany, January 14, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical ...